﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Cardiovascular and Thoracic Research</JournalTitle>
      <Issn>2008-5117</Issn>
      <Volume>15</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>06</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Human cardiac organoids: A recent revolution in disease modeling and regenerative medicine</ArticleTitle>
    <FirstPage>68</FirstPage>
    <LastPage>72</LastPage>
    <ELocationID EIdType="doi">10.34172/jcvtr.2023.31830</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Neda</FirstName>
        <LastName>Roshanravan</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8173-6532</Identifier>
      </Author>
      <Author>
        <FirstName>Samad</FirstName>
        <LastName>Ghaffari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6806-9387</Identifier>
      </Author>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Bastani</LastName>
      </Author>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Pahlavan</LastName>
      </Author>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Asghari</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad Amin</FirstName>
        <LastName>Doustvandi</LastName>
      </Author>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Jalilzadeh- Razin</LastName>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Dastouri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-3882-0728</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>REVIEW</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jcvtr.2023.31830</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>06</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <Abstract>Three-dimensional (3D) myocardial tissues for studying human heart biology, physiology and pharmacology have recently received lots of attention. Organoids as 3D mini-organs are created from multiple cell types (i.e. induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs)) with other supporting co-cultured cells such as endothelial cells or fibroblasts. Cardiac organoid culture technologies are bringing about significant advances in organ research and allows for the establishment of tissue regeneration and disease modeling. The present review provides an overview of the recent advances in human cardiac organoid platforms in disease biology and for cardiovascular regenerative medicine.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Organoid</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Regenerative Medicine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Three-Dimensional Culture</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pluripotent Stem Cells</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>